Perimenopause, fatigue and mitochondrial health: a practical UK guide

Perimenopause is often described through hot flushes and irregular periods, but many people first notice a quieter problem: energy is less predictable. Workouts feel harder. Sleep is lighter. Brain fog appears on days that used to feel ordinary. The temptation is to explain all of it with one word — hormones — and then either ignore it or over-optimise it.

A better approach is more practical. Perimenopause is a real biological transition, and hormonal fluctuation can affect sleep, mood, body composition, temperature regulation and recovery. But fatigue is multi-factorial. Iron status, B12, vitamin D, thyroid function, glucose regulation, inflammation, alcohol, stress and training load can all sit in the same picture.

1. Why energy can change in perimenopause

Perimenopause is the transition before menopause, when ovarian hormone patterns become less predictable. Periods may change in timing or flow, sleep may become lighter, temperature symptoms may appear, and mood or concentration can shift. These changes can affect energy even when routine blood tests look broadly normal.

Sleep is a common route. Night sweats, early waking or anxiety can reduce recovery before the day has even started. Another route is training response: the same exercise load that once felt productive may now need more deliberate recovery. That does not mean exercise is harmful. It means the dose may need adjusting.

The important clinical point is that perimenopause is not a diagnosis for every symptom. Heavy bleeding may lower iron stores. Dietary change may affect B12 or protein intake. Thyroid disease, anaemia, depression, long COVID and cardiometabolic risk can overlap with the same age window. Context protects you from both dismissal and over-treatment.

2. Where mitochondrial health fits

Mitochondria help convert nutrients and oxygen into usable cellular energy. They are involved in muscle function, recovery, temperature regulation and many processes that feel relevant when energy drops. It is reasonable to ask whether cellular energy is part of the perimenopause fatigue story.

It is not reasonable to make mitochondria the new catch-all explanation. A person can feel exhausted because sleep is poor, ferritin is low, training load is too high, glucose swings are frequent, inflammation is raised or life stress is relentless. Mitochondrial function sits inside that broader system, not above it.

For MeScreen, the useful question is not “are my mitochondria broken?” It is “does my cellular-energy and biomarker picture support the way I feel, and does it point to a sensible next action?” That keeps testing grounded and avoids the supplement-first rabbit hole.

3. Biomarkers that can add useful context

When fatigue persists, a structured biomarker review can help separate likely contributors. Iron and ferritin matter because heavier or more irregular bleeding can reduce iron stores before frank anaemia is obvious. B12 and folate matter for red blood cell production and neurological function. Vitamin D can be low in the UK, especially after winter or with limited sunlight.

Glucose and HbA1c help show whether energy dips may be part of a metabolic pattern. Lipids and ApoB add cardiovascular context, which becomes more relevant as lifetime risk accumulates. hs-CRP can suggest inflammatory load, though it is non-specific and should be interpreted calmly rather than treated as a diagnosis.

None of these markers should be read in isolation. A slightly low result may be less important than a cluster: poor sleep, heavy periods, low ferritin, low B12 and reduced exercise tolerance tell a different story from a single wearable metric on a stressful week.

4. Symptom patterns worth tracking

Write down the pattern before buying more tests. Note period changes, sleep quality, night sweats, alcohol intake, training, resting heart rate, HRV if you use it, mood, concentration, breathlessness and recovery after exercise. The aim is not to become a spreadsheet patient. It is to stop relying on memory when symptoms fluctuate.

Patterns help prioritise action. Fatigue that tracks poor sleep needs a different first response from fatigue with heavy bleeding and breathlessness. Brain fog with skipped meals suggests a different line of questioning from brain fog with tingling, numbness or marked B12 risk factors.

A simple monthly review is often enough: what changed, what improved, what worsened, and what would make a clinician conversation more productive?

5. Practical steps before and after testing

Start with the foundations that genuinely change energy: regular movement, enough protein and iron-rich foods, sensible alcohol boundaries, resistance training, daylight, and a realistic sleep routine. For many people, the unglamorous basics make biomarker results easier to interpret because there is less background noise.

If you test, decide in advance what each result might change. Low ferritin may prompt a GP discussion, nutrition review or repeat testing plan. Low B12 may need dietary and absorption context. Raised HbA1c may shift meal timing, activity and clinical follow-up. A result without an action plan can become expensive reassurance or unnecessary anxiety.

6. Red flags are not wellness projects

Some symptoms need appropriate medical advice rather than a private optimisation plan. Seek help for chest pain, fainting, severe breathlessness, blackouts, new neurological symptoms, unexplained weight loss, very heavy bleeding, bleeding after sex, severe depression or any symptom that feels urgent or unsafe.

Private biomarker testing can support prevention and better conversations. It should not delay diagnosis or urgent care. The safest use of MeScreen-style data is to organise questions, not to replace clinical judgement.

Bottom line

Perimenopause can change energy, sleep and recovery, but fatigue still deserves a full context. Hormones, mitochondria, iron, B vitamins, vitamin D, glucose, inflammation and lifestyle all interact. The practical goal is to identify which levers are most likely to matter for you.

MeScreen can help add structure to that process by combining cellular-health and biomarker context with a clear action plan. The aim is not to chase perfect numbers. It is to make the next health decision less vague.

References

1. NHS. Menopause. Accessed 10 May 2026.
2. NICE NG23. Menopause: identification and management. Accessed 10 May 2026.
3. NHS. Iron deficiency anaemia. Accessed 10 May 2026.